Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$42.05 - $47.77 $3.26 Million - $3.7 Million
77,530 Added 2138.76%
81,155 $3.53 Million
Q1 2022

May 16, 2022

BUY
$40.23 - $47.74 $1,810 - $2,148
45 Added 1.26%
3,625 $156,000
Q4 2021

Feb 15, 2022

BUY
$38.88 - $45.31 $4,237 - $4,938
109 Added 3.14%
3,580 $157,000
Q3 2021

Nov 15, 2021

BUY
$38.79 - $43.16 $2,676 - $2,978
69 Added 2.03%
3,471 $136,000
Q1 2021

May 17, 2021

SELL
$34.27 - $40.01 $5.68 Million - $6.63 Million
-165,798 Reduced 97.99%
3,402 $121,000
Q3 2020

Nov 16, 2020

SELL
$38.11 - $42.99 $571 - $644
-15 Reduced 0.01%
169,200 $6.38 Million
Q2 2020

Aug 14, 2020

BUY
$37.87 - $43.58 $568 - $653
15 Added 0.01%
169,215 $6.95 Million
Q1 2020

May 26, 2020

BUY
$32.47 - $48.83 $5.47 Million - $8.23 Million
168,500 Added 24071.43%
169,200 $6.41 Million
Q1 2020

May 14, 2020

SELL
$32.47 - $48.83 $5.47 Million - $8.23 Million
-168,500 Reduced 99.59%
700 $27,000
Q4 2019

Feb 14, 2020

SELL
$42.0 - $48.25 $11,802 - $13,558
-281 Reduced 0.17%
169,200 $8.01 Million
Q3 2019

Nov 14, 2019

BUY
$40.46 - $43.52 $7,808 - $8,399
193 Added 0.11%
169,481 $7.17 Million
Q2 2019

Aug 14, 2019

BUY
$39.4 - $42.7 $6.64 Million - $7.2 Million
168,573 Added 23576.64%
169,288 $6.77 Million
Q1 2019

May 15, 2019

SELL
$38.57 - $42.69 $9,719 - $10,757
-252 Reduced 26.06%
715 $30,000
Q4 2018

Feb 14, 2019

BUY
$37.8 - $42.69 $9,525 - $10,757
252 Added 35.24%
967 $37,000
Q3 2018

Nov 14, 2018

SELL
$39.75 - $42.69 $4,054 - $4,354
-102 Reduced 12.48%
715 $29,000
Q2 2018

Aug 14, 2018

BUY
$39.61 - $42.76 $4,040 - $4,361
102 Added 14.27%
817 $33,000
Q1 2018

May 15, 2018

SELL
$36.18 - $40.15 $412,452 - $457,710
-11,400 Reduced 94.1%
715 $28,000
Q4 2017

Feb 14, 2018

SELL
$35.34 - $41.9 $487,692 - $578,220
-13,800 Reduced 53.25%
12,115 $428,000
Q3 2017

Nov 14, 2017

BUY
$39.44 - $41.55 $1.02 Million - $1.08 Million
25,915
25,915 $1.02 Million

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $69.3B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track 1832 Asset Management L.P. Portfolio

Follow 1832 Asset Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 1832 Asset Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on 1832 Asset Management L.P. with notifications on news.